Think About Juluca for HIV Patients Who Can't Tolerate Other Meds

February 2018

Juluca (jah-LOO-kah, dolutegravir/rilpivirine) will be the first two-drug combo that's a COMPLETE treatment regimen for HIV.

Most patients use THREE meds to treat HIV...often two nucleoSIDE/ nucleoTIDE reverse transcriptase inhibitors (NRTIs) PLUS another antiretroviral from a different class.

Juluca doesn't have an NRTI. It combines the integrase inhibitor, dolutegravir (Tivicay), with the NON-nucleoside reverse transcriptase inhibitor, rilpivirine (Edurant). It's a single tablet taken once daily.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote